Rapid Detection of New Delhi Metallo-β-Lactamase Gene Using Recombinase-Aided Amplification Directly on Clinical Samples From Children
Yanling Feng,Guanhua Xue,Junxia Feng,Chao Yan,Jinghua Cui,Lin Gan,Rui Zhang,Hanqin Zhao,Wenjian Xu,Nannan Li,Shiyu Liu,Shuheng Du,Weiwei Zhang,Hailan Yao,Jun Tai,Lijuan Ma,Ting Zhang,Dong Qu,Yongxiang Wei,Jing Yuan
DOI: https://doi.org/10.3389/fmicb.2021.691289
IF: 5.2
2021-07-22
Frontiers in Microbiology
Abstract:New Delhi metallo-β-lactamase, a metallo-β-lactamase carbapenemase type, mediates resistance to most β-lactam antibiotics including penicillins, cephalosporins, and carbapenems. Therefore, it is important to detect bla NDM genes in children’s clinical samples as quickly as possible and analyze their characteristics. Here, a recombinase-aided amplification (RAA) assay, which operates in a single one-step reaction tube at 39°C in 5−15 min, was established to target bla NDM genes in children’s clinical samples. The analytical sensitivity of the RAA assay was 20 copies, and the various bacterial types without bla NDM genes did not amplify. This method was used to detect bla NDM genes in 112 children’s stool samples, 10 of which were tested positive by both RAA and standard PCR. To further investigate the characteristics of carbapenem-resistant bacteria carrying bla NDM in children, 15 carbapenem-resistant bacteria ( Escherichia coli , Klebsiella pneumoniae , Acinetobacter baumannii , Citrobacter freundii , Klebsiella oxytoca , Acinetobacter junii , and Proteus mirabilis ) were isolated from the 10 samples. Notably, more than one bacterial type was isolated from three samples. Most of these isolates were resistant to cephalosporins, cefoperazone-sulbactam, piperacillin-tazobactam, ticarcillin-clavulanic acid, aztreonam, co-trimoxazole, and carbapenems. bla NDM – 1 and bla NDM – 5 were the two main types in these samples. These data show that the RAA assay has potential to be a sensitive and rapid bla NDM gene screening test for clinical samples. The common existence of bla NDM and multi-drug resistance genes presents major challenges for pediatric treatment.
microbiology